(+)-myristinins A and D from Knema elegans, which inhibit DNA polymerase β and cleave DNA

被引:50
作者
Deng, JZ [1 ]
Starck, SR [1 ]
Li, SS [1 ]
Hecht, SM [1 ]
机构
[1] Univ Virginia, Dept Biol & Chem, Charlottesville, VA 22903 USA
来源
JOURNAL OF NATURAL PRODUCTS | 2005年 / 68卷 / 11期
关键词
D O I
10.1021/np058064g
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
A survey of crude plant extracts for DNA polymerase inhibitors resulted in the identification of a methyl ethyl ketone extract prepared from Knema elegans that strongly inhibited the enzyme. Subsequent bioassay-guided fractionation of the extract, using an assay to monitor the activity of DNA polymerase beta, led to the isolation of two potent inhibitors, (+)-myristinins A (1) and D (2), which are known flavans having unusual structures. (+)-Myristinins A and D exhibited IC50 values of 12 and 4.3 mu M, respectively, as inhibitors of DNA polymerase beta in the presence of bovine serum albumin (BSA), and 2.7 and 1:2 mu M in the absence of BSA. As such, they are the most potent DNA polymerase inhibitors reported to date. Compounds 1 and 2 potentiated the cytotoxicity of bleomycin toward cultured P388D(1) cells, reducing the number of viable cells by at least 30% when employed at 9 mu M concentration for 6 h in the presence of an otherwise nontoxic concentration of bleomycin (75 nM). Principles 1 and 2 also induced strong Cu2+-dependent DNA strand scission in a DNA cleavage assay. Accordingly, 1 and 2 exhibit two activities, namely, DNA polymerase beta inhibition and DNA damage.
引用
收藏
页码:1625 / 1628
页数:4
相关论文
共 46 条
  • [1] EXPRESSION OF HUMAN DNA POLYMERASE-BETA IN ESCHERICHIA-COLI AND CHARACTERIZATION OF THE RECOMBINANT ENZYME
    ABBOTTS, J
    SENGUPTA, DN
    ZMUDZKA, B
    WIDEN, SG
    NOTARIO, V
    WILSON, SH
    [J]. BIOCHEMISTRY, 1988, 27 (03) : 901 - 909
  • [2] AKIRA M, 1992, J PHARMACOL EXP THER, V263, P1302
  • [3] ENHANCED REPAIR OF A CISPLATIN-DAMAGED REPORTER CHLORAMPHENICOL-O-ACETYLTRANSFERASE GENE AND ALTERED ACTIVITIES OF DNA-POLYMERASES ALPHA AND BETA, AND DNA-LIGASE IN CELLS OF A HUMAN-MALIGNANT GLIOMA FOLLOWING IN-VIVO CISPLATIN THERAPY
    ALIOSMAN, F
    BERGER, MS
    RAIRKAR, A
    STEIN, DE
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, 54 (01) : 11 - 19
  • [4] Beard WA, 1995, METHOD ENZYMOL, V262, P98
  • [5] SYNTHESIS OF CONDENSED TANNINS .1. STEREOSELECTIVE AND STEREOSPECIFIC SYNTHESES OF OPTICALLY PURE 4-ARYLFLAVAN-3-OLS, AND ASSESSMENT OF THEIR ABSOLUTE STEREOCHEMISTRY AT C-4 BY MEANS OF CIRCULAR-DICHROISM
    BOTHA, JJ
    YOUNG, DA
    FERREIRA, D
    ROUX, DG
    [J]. JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1, 1981, (04): : 1213 - 1219
  • [6] SOME PRACTICAL CONSIDERATIONS AND APPLICATIONS OF THE NATIONAL-CANCER-INSTITUTE IN-VITRO ANTICANCER DRUG DISCOVERY SCREEN
    BOYD, MR
    PAULI, KD
    [J]. DRUG DEVELOPMENT RESEARCH, 1995, 34 (02) : 91 - 109
  • [7] Overexpression of DNA polymerase β in cell results in a mutator phenotype and a decreased sensitivity to anticancer drugs
    Canitrot, Y
    Cazaux, C
    Fréchet, M
    Bouayadi, K
    Lesca, C
    Salles, B
    Hoffmann, JS
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (21) : 12586 - 12590
  • [8] DNA repair: Enzymatic mechanisms and relevance to drug response
    Chaney, SG
    Sancar, A
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (19): : 1346 - 1360
  • [9] Inhibitors of DNA polymerase β from Schoepfia californica
    Chen, J
    Zhang, YH
    Wang, LK
    Sucheck, SJ
    Snow, AM
    Hecht, SM
    [J]. CHEMICAL COMMUNICATIONS, 1998, (24) : 2769 - 2770
  • [10] EXPRESSION OF ACTIVE-RAT DNA POLYMERASE-BETA IN ESCHERICHIA-COLI
    DATE, T
    YAMAGUCHI, M
    HIROSE, F
    NISHIMOTO, Y
    TANIHARA, K
    MATSUKAGE, A
    [J]. BIOCHEMISTRY, 1988, 27 (08) : 2983 - 2990